journal cover

De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation

Clinical Transplantation

Sep 4, 2015

Martina KochBjoern Nashan

Download from

Publisher
PubMed

Abstract

ABO-incompatible (ABOi) kidney transplantation (KTx) has become an accepted therapeutic option in renal replacement therapy for patients without a blood group-compatible living donor. Using different desensitization strategies, most centers apply B-cell depletion with rituximab and main...read more

Mentioned in this Paper

Tumor Virus Infections
Health Center
Kidney Function Tests
Treatment Protocols
T-Lymphocyte
Decreased Immunologic Activity [PE]
Strategy
Virus Diseases
CYTOMEGALOVIRUS ANTIGEN
Blood Group H Type 1 Antigen
Paper Details
References
  • References32
  • Citations5
1234
  • References32
  • Citations5
1

Feeds With Similar Papers

Postoperative Infections

Postoperative infections are infections that often originate at the surgical incision itself after an operation. Discover the latest research on postoperative infections here.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Cytomegalovirus infection

Cytomegalovirus is a common infection among adults with little to no symptoms. Cytomegalovirus infection among immunocompromised hosts or organ transplant recipients can lead to increased morbidity and mortality. Discover the latest research here.

Immune Tolerance

Immune tolerance happens when the immune system is not responsive to a substance or organism and does not elicit an immune response. This is a normal physiological response for some antigens, especially when detecting self from non-self. This has been a potential area of therapy for some disorders. Here is the latest research on immune tolerance.

Oncoviral Profiles

Viral infections have been found to be responsible for causing some cancer types in humans. The collection of the viral genome gathered from cancer genome sequencing data can help identify the origin of the cancer. Here is the latest research on oncoviral profiles.

© 2020 Meta ULC. All rights reserved

De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation

Clinical Transplantation

Sep 4, 2015

Martina KochBjoern Nashan

PMID: 26333844

DOI: 10.1111/ctr.12624

Abstract

ABO-incompatible (ABOi) kidney transplantation (KTx) has become an accepted therapeutic option in renal replacement therapy for patients without a blood group-compatible living donor. Using different desensitization strategies, most centers apply B-cell depletion with rituximab and main...read more

Mentioned in this Paper

Tumor Virus Infections
Health Center
Kidney Function Tests
Treatment Protocols
T-Lymphocyte
Decreased Immunologic Activity [PE]
Strategy
Virus Diseases
CYTOMEGALOVIRUS ANTIGEN
Blood Group H Type 1 Antigen

Feeds With Similar Papers

Postoperative Infections

Postoperative infections are infections that often originate at the surgical incision itself after an operation. Discover the latest research on postoperative infections here.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Related Papers

Paper Details
References
  • References32
  • Citations5
1234
  • References32
  • Citations5
1

Download from

Publisher
PubMed
/papers/de-novo-mtor-inhibitor-based-immunosuppression-in/26333844